Pharmacokinetics of caffeic acid phenethyl ester and its catechol‐ring fluorinated derivative following intravenous administration to rats
- 17 June 2009
- journal article
- research article
- Published by Wiley in Biopharmaceutics & Drug Disposition
- Vol. 30 (5) , 221-228
Abstract
The pharmacokinetic profiles of caffeic acid phenethyl ester (CAPE) and its catechol‐ring fluorinated derivative (FCAPE) were determined in rats after intravenous administration of 5, 10 or 20 mg/kg for CAPE and 20 mg/kg for FCAPE, respectively. The plasma concentrations of CAPE and FCAPE were measured using a validated liquid chromatography tandem mass spectrometric method. The pharmacokinetic parameters were estimated using non compartmental analysis (NCA) and biexponential fit. The results showed that the area under the plasma concentration‐time curve for CAPE treatment increased in a proportion greater than the increase in dose from 5 to 20 mg/kg of CAPE. Total body clearance values for CAPE ranged from 42.1 to 172 ml/min/kg (NCA) and decreased with the increasing dose of CAPE. Similarly, the volume of distribution values for CAPE ranged from 1555 to 5209 ml/kg, decreasing with increasing dose. The elimination half‐life for CAPE ranged from 21.2 to 26.7 min and was independent of dose. That FCAPE was distributed extensively into rat tissues and eliminated rapidly was indicated by a high value of volume of distribution and similar short elimination half‐life as that of CAPE. Copyright © 2009 John Wiley & Sons, Ltd.Keywords
This publication has 24 references indexed in Scilit:
- Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cellsThe Journal of Nutritional Biochemistry, 2006
- Caffeic acid phenethyl ester modulatesHelicobacter pylori‐induced nuclear factor‐kappa B and activator protein‐1 expression in gastric epithelial cellsBritish Journal of Pharmacology, 2005
- Novel and therapeutic effect of caffeic acid and caffeic acid phenyl ester on hepatocarcinoma cells: complete regression of hepatoma growth and metastasis by dual mechanismThe FASEB Journal, 2004
- Caffeic Acid Phenethyl Ester Inhibits T-Cell Activation by Targeting Both Nuclear Factor of Activated T-Cells and NF-κB Transcription FactorsThe Journal of Pharmacology and Experimental Therapeutics, 2004
- Free Radical Scavenging and Antioxidative Activity of Caffeic Acid Amide and Ester Analogues: Structure−Activity RelationshipJournal of Agricultural and Food Chemistry, 2001
- Antioxidant Activities of Caffeic Acid and Its Related Hydroxycinnamic Acid CompoundsJournal of Agricultural and Food Chemistry, 1997
- The effect of propolis and its components on eicosanoid production during the inflammatory responseProstaglandins, Leukotrienes and Essential Fatty Acids, 1996
- Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-kappa B.Proceedings of the National Academy of Sciences, 1996
- Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compoundsBiochemical Pharmacology, 1994
- Inhibitors of human immunodeficiency virus integrase.Proceedings of the National Academy of Sciences, 1993